ONCO Earnings

Quarterly EPS
$-12454.00
Q3 2024
$-14705.32
Q4 2024
$-2272.50
Q1 2025
$-237.91
Q2 2025
$-312.50
Q3 2025
$181.27
Q4 2025
$-67.10
Q1 2026
$-1.28
Q2 2026
Latest Revenue17.1K
Latest Net Income-2867303
EPS & Revenue Trend
PeriodEPSRevenueNet IncomeRev YoYEPS YoY
Q2 2026-$1.2817.1K-2867303-83.9%+99.5%
Q1 2026-$67.1021.5K-4214875-78.9%+97.0%
Q4 2025$181.27303.6K5.7M-57.4%+101.2%
Q3 2025-$312.50303.7K-8783702-25.4%+97.5%
Q2 2025-$237.91106.5K-2372442-84.9%+99.8%
Q1 2025-$2,272.50101.6K-8545885-85.5%+97.3%
Q4 2024-$14,705.32712.0K-29438342+1,117.8%+92.6%
Q3 2024-$12,454.00406.9K-3827405
Q2 2024-$109,579.50704.8K-14306704
Q1 2024-$85,340.00700.4K-11118572
Q4 2023-$198,864.2958.5K-22350872
Onconetix (ONCO) — Earnings